Protocol · Brain & Cognitive Health
Discirculatory Encephalopathy (Chronic Cerebrovascular Insufficiency) Protocol
Ginkgo Biloba and Citicoline (CDP-Choline) are the core of this stack, with 6 supporting supplements. Each row gives the amount the protocol lists and the grade our evidence database holds for that supplement in Discirculatory Encephalopathy (Chronic Cerebrovascular Insufficiency).
We are re-verifying the studies cited on protocol pages; only confirmed citations are shown.
The stack
8 supplements · 1 graded
| Grade | Supplement | Amount listed | Why it’s in the stack | Evidence on file | Shop |
|---|---|---|---|---|---|
| Primary stackThe core of this protocol | |||||
| Ginkgo Biloba | Amount listed: 120–240 mg standardized extract (24% flavone glycosides, 6% terpene lactones) daily | Improves cerebral blood flow, has antioxidant effects, and may protect brain cells from ischemic damage | Not graded yet | ||
| Citicoline (CDP-Choline) | Amount listed: 500–2,000 mg daily | Supports brain cell membrane integrity and neurotransmitter synthesis; may improve cognitive function after ischemic events | Not graded yet | ||
| Supporting stackListed as additions to the core | |||||
| Vinpocetine | Amount listed: 15–30 mg daily in divided doses | Derived from periwinkle; improves cerebral blood flow and has neuroprotective effects
| Grade C for Cognitive Decline1 study · 20 people | ||
| Omega-3 Fatty Acids | Amount listed: 2–3 g EPA+DHA daily | Support brain cell membrane function and have anti-inflammatory effects on blood vessels | Not graded yet | ||
| Phosphatidylserine | Amount listed: 100–300 mg daily | Brain cell membrane component; may support cognitive function in age-related decline | Not graded yet | ||
| Vitamin D | Amount listed: 2,000–4,000 IU daily (target 40–60 ng/mL) | Deficiency associated with cerebrovascular disease and cognitive decline | Not graded yet | ||
| B Vitamins (B6, B12, Folate) | Amount listed: B-complex with B12 500–1,000 mcg, folate 400–800 mcg, B6 25–50 mg daily | Reduce homocysteine which is a risk factor for cerebrovascular disease | Not graded yet | ||
| Coenzyme Q10 | Amount listed: 100–200 mg daily | Antioxidant that supports brain energy metabolism; may protect against oxidative damage | Not graded yet | ||
Shop the evidence-backed picks
Support alongside medical care. These supplements are not a treatment for Discirculatory Encephalopathy (Chronic Cerebrovascular Insufficiency). If you are being treated for it, talk to your clinician before adding one: supplements can interact with medicines.
The collection holds the supplements we grade A or B for its theme, in third-party tested products where the catalog has them. It opens in our Fullscript store. You can look through it without signing in; Fullscript asks for a free account to order.
Or shop one supplement
Each opens third-party tested products, matched to the dose above where we can.
- Grade C
We earn from purchases made in our Fullscript store, and links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Full disclosure
How this protocol works
In plain language
Discirculatory encephalopathy (DE), also known as chronic cerebrovascular insufficiency, is a condition where reduced blood flow to the brain over time causes progressive cognitive decline, memory problems, and neurological symptoms. This term is commonly used in Eastern European and Russian medicine; in Western medicine, similar conditions are called vascular cognitive impairment or cerebral small vessel disease. Causes include atherosclerosis, hypertension, and diabetes - all of which damage the small blood vessels supplying the brain.
CRITICAL: Cerebrovascular disease causing cognitive decline requires medical evaluation and management of underlying risk factors (hypertension, diabetes, high cholesterol, smoking). If you experience sudden changes in cognition, speech, or movement, seek immediate medical care as this may indicate stroke. These supplements support brain health but don't replace medical treatment.
Ginkgo Biloba* improves cerebral blood flow and has antioxidant properties that may protect brain cells. Multiple studies show benefits for cognitive symptoms related to cerebrovascular insufficiency.
Citicoline (CDP-Choline)* is a building block for brain cell membranes and supports the production of neurotransmitters. It has been studied extensively for cognitive impairment after strokes and in vascular cognitive decline.
Vinpocetine* is derived from periwinkle and improves blood flow to the brain. It has been used in Europe for decades for cerebrovascular conditions.
Omega-3 Fatty Acids* are essential components of brain cell membranes and have anti-inflammatory effects. They support both brain structure and vascular health.
Phosphatidylserine* is a natural component of brain cell membranes that declines with age. Supplementation may support cognitive function.
Vitamin D* deficiency is associated with both cerebrovascular disease and cognitive decline. Maintaining adequate levels supports brain health.
B Vitamins* (B6, B12, folate) lower homocysteine, an amino acid that damages blood vessels and is a risk factor for cerebrovascular disease.
CoQ10* supports brain energy production and has antioxidant effects that may protect against oxidative damage from reduced blood flow.
Expected timeline: Ginkgo and vinpocetine: may see improvements in 4-12 weeks. Citicoline: 2-4 weeks for initial effects. These supplements provide ongoing support; cognitive changes from vascular disease may stabilize or improve slowly over months.